Compare BXC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BXC | CYRX |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | 1700 | 1100 |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.5M | 814.9M |
| IPO Year | 2004 | 2008 |
| Metric | BXC | CYRX |
|---|---|---|
| Price | $80.37 | $15.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $71.50 | $13.31 |
| AVG Volume (30 Days) | 99.7K | ★ 426.2K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 0.62 | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $5.04 | $11.06 |
| Revenue Next Year | $5.09 | $8.45 |
| P/E Ratio | $129.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $44.78 | $7.61 |
| 52 Week High | $93.80 | $17.20 |
| Indicator | BXC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 42.31 |
| Support Level | $73.99 | $14.55 |
| Resistance Level | $80.57 | $16.87 |
| Average True Range (ATR) | 3.48 | 0.63 |
| MACD | -1.12 | -0.12 |
| Stochastic Oscillator | 50.60 | 2.36 |
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.